These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7902482)

  • 21. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease.
    Rhyne J; Ryan MJ; White C; Chimonas T; Miller M
    J Mol Med (Berl); 2006 Aug; 84(8):647-50. PubMed ID: 16855848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
    Gille A; D'Andrea D; Tortorici MA; Hartel G; Wright SD
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):953-963. PubMed ID: 29437574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein A-I (Glu 198----Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia.
    Strobl W; Jabs HU; Hayde M; Holzinger T; Assmann G; Widhalm K
    Pediatr Res; 1988 Aug; 24(2):222-8. PubMed ID: 3141894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique genetic and biochemical presentation of fish-eye disease.
    Kuivenhoven JA; van Voorst tot Voorst EJ; Wiebusch H; Marcovina SM; Funke H; Assmann G; Pritchard PH; Kastelein JJ
    J Clin Invest; 1995 Dec; 96(6):2783-91. PubMed ID: 8675648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of the analysis of lipoproteins after myocardial infarction].
    Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J
    Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA; Johnson O; Ericsson M; Tollin C
    Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol efflux from macrophages mediated by high-density lipoprotein subfractions, which differ principally in apolipoprotein A-I and apolipoprotein A-II ratios.
    von Hodenberg E; Heinen S; Howell KE; Luley C; Kübler W; Bond HM
    Biochim Biophys Acta; 1991 Nov; 1086(2):173-84. PubMed ID: 1932099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1990 Jan; 85(1):144-51. PubMed ID: 2104877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
    Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
    Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.
    Maciejko JJ; Holmes DR; Kottke BA; Zinsmeister AR; Dinh DM; Mao SJ
    N Engl J Med; 1983 Aug; 309(7):385-9. PubMed ID: 6410239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
    Assmann G; von Eckardstein A; Funke H
    Circulation; 1993 Apr; 87(4 Suppl):III28-34. PubMed ID: 8462178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
    Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polymorphism (RFLP-PstI) of the apoprotein A-I gene in a healthy population. Its relation to high-density lipoproteins].
    Balanyà J; Marsal S; LaVille A; Margalef J; Turner PR; Masana L
    Med Clin (Barc); 1993 Jan; 100(3):90-3. PubMed ID: 8093913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The measurement of apolipoprotein A-I and A-II levels of human plasma high density lipoprotein (HDL) by single radial immunodiffusion (SRID) method].
    Miyahara T; Murai A; Kameyama M
    Nihon Ronen Igakkai Zasshi; 1982 Nov; 19(6):583-7. PubMed ID: 6820093
    [No Abstract]   [Full Text] [Related]  

  • 36. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lovastatin and gemfibrozil on high-density lipoprotein subfraction density and composition in patients with familial hypercholesterolemia.
    Tilly-Kiesi M; Tikkanen MJ
    J Lab Clin Med; 1992 Jul; 120(1):103-10. PubMed ID: 1613316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.
    Hernandez AF; Pla A; Valenzuela A; Gil F; Hougen HP; Villanueva E
    Int J Legal Med; 1993; 105(6):321-4. PubMed ID: 8390852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Indicator for HDL Functionality.
    Irino Y; Toh R; Ishida T
    J Atheroscler Thromb; 2019 Nov; 26(11):945-946. PubMed ID: 31167979
    [No Abstract]   [Full Text] [Related]  

  • 40. Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?
    Razavi AC; Jain V; Grandhi GR; Patel P; Karagiannis A; Patel N; Dhindsa DS; Liu C; Desai SR; Almuwaqqat Z; Sun YV; Vaccarino V; Quyyumi AA; Sperling LS; Mehta A
    J Clin Endocrinol Metab; 2024 Jan; 109(2):321-332. PubMed ID: 37437107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.